About: Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • In the past three decades, nitric oxide has been well established as an important bioactive molecule implicated in regulation of cardiovascular, nervous, and immune systems. Therefore, it is not surprising that much effort has been made to find specific inhibitors of nitric oxide synthases (NOS), the enzymes responsible for production of nitric oxide. Among the many NOS inhibitors developed to date, inhibitors based on derivatives and analogues of arginine are of special interest, as this category includes a relatively high number of compounds with good potential for experimental as well as clinical application.
  • In the past three decades, nitric oxide has been well established as an important bioactive molecule implicated in regulation of cardiovascular, nervous, and immune systems. Therefore, it is not surprising that much effort has been made to find specific inhibitors of nitric oxide synthases (NOS), the enzymes responsible for production of nitric oxide. Among the many NOS inhibitors developed to date, inhibitors based on derivatives and analogues of arginine are of special interest, as this category includes a relatively high number of compounds with good potential for experimental as well as clinical application. (en)
Title
  • Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges
  • Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges (en)
skos:prefLabel
  • Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges
  • Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges (en)
skos:notation
  • RIV/68081707:_____/12:00390403!RIV13-AV0-68081707
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(ED1.100/02/0123), P(GA524/08/1753)
http://linked.open...iv/cisloPeriodika
  • 2012
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 123638
http://linked.open...ai/riv/idVysledku
  • RIV/68081707:_____/12:00390403
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • METHYL-L-ARGININE; HIGHLY SELECTIVE INHIBITORS; CARDIOVASCULAR RISK-FACTOR (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [D24FAD94C232]
http://linked.open...i/riv/nazevZdroje
  • Mediators of Inflammation
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 2012
http://linked.open...iv/tvurceVysledku
  • Kubala, Lukáš
  • Lojek, Antonín
  • Valacchi, G.
  • Víteček, J.
http://linked.open...ain/vavai/riv/wos
  • 000308758200001
issn
  • 0962-9351
number of pages
http://bibframe.org/vocab/doi
  • 10.1155/2012/318087
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software